PT ENSEVAL PUTERA MEGATRADING TBK. · name to PT Enseval Putera Megatrading 1994 –PT Enseval...

COMPANY UPDATEPT ENSEVAL PUTERA MEGATRADING TBK.

Ended June 30, 2014 (Unaudited)

Passion For Excellence:

The Journey to Excellence

TABLE OF CONTENT

SECTION 1 Enseval In Brief 3

SECTION 2 Business Overview 8

SECTION 3 Operational Overview 20

SECTION 4 Financial Overview 23

SECTION 5 2014 Overview 28

SECTION 1ENSEVAL IN BRIEF

ENSEVAL IN BRIEF

4

Established in October 1973 with the aim of managing the distribution function because of theseparation of the distribution division from the marketing and production division of PT KalbeFarma;

On 1 August 1994, the Company listed its shares on the Jakarta Stock Exchange; The Company focuses its activities on distribution and trading services under 5 divisions :

Pharmaceutical products sales and distribution, which comprised of patented medicines as wellas generic medicines;

Consumer products, non prescription medicine and nutrition sales and distribution; Medical equipment sales and distribution, which include marketing activities; Raw material sales and distribution, which include veterinary product; Healthcare services.

Integrated healthcare Distribution and Logistic services company through Service Excellence, Technology Driven and Strong Leadership.

5

1973 – Incorporation of PT Enseval

1988 – Incorporation of PT Arya Gupta Cempaka

1993 – PT Arya Gupta Cempaka changed its name to PT EnsevalPutera Megatrading

1994 – PT Enseval Putera Megatrading Tbk conducted its Initial Public Offering

2003 – Incorporation of PT Millenia Dharma Insani

2007 – Incorporation of PT Enseval Medika Prima and PT Global Chemindo Megatrading

2008 – Incorporation of PT Renalmed Tiara Utama

2011 – The Company Right Issue to finance expansion

2012 – Obtained ISO 9001:2008 certification

2013 – Makassar, Bandung and Bekasi awarded – BPOM awards these centres for Good Distribution Practice in Pharmaceuticals.

More than 40 years in business, Enseval constanly makes the best effort to obtain sustainable growth.

ENSEVAL IN BRIEF

ENSEVAL IN BRIEF

6

Currently, the Company owns and operates 45 branches and 23 branches under subsidiaries locatedthroughtout in Indonesia;

The Company also owns 2 Regional Distribution Center (RDC) located in Jakarta and Surabaya; For the information technology platform, the Company now is using Oracle E-Business Suite Release

12; Until the end of june 2014, the Company's operation supported by over than 7,300 employees.

Become Market Leader Through high quality of information Technology system and competent human resources.

Award & Sertification Until June 2014

2014 OVERVIEW

7

• ORACLE - EXA Trend-Setter Award.

• FRONTIER - The Best Building and Managing Corporate Image.

• FROST & SULLIVAN - Indonesia Pharmaceutical Distributor of the year.

• HERMINA HOSPITAL GROUP - The Best Pharmaceutical Distributor.

• NIVEA - The Best Weighted Distributor.

• Rekor Bisnis Indonesia - Pharmaceutical Distributor with the Most Outlet Coverage.

• The Most Powerful Distribution Performance– EXTRA JOSS

– KOMIX

8

• AZ/NZS ISO 9001:2008 Certified

• BS OHSAS 18001:2007 Certified

• Good Distribution Practices Certified

• Cara Distribusi Obat yang Baik (CDOB Certified)

Award & Sertification Until June 2014

2014 OVERVIEW

SECTION 2BUSINESS OVERVIEW

*Description of net sales per products as describe below :

BUSINESS OVERVIEW

Net Sales per Products until June 30, 2014

10

Products Portfolio Net Sales (Rp)Contribution to Total Net

Sales

Consumer Products 3,664,865,320,957 44.60%

Prescription Medicines 2,340,888,691,551 28.49%

Non Prescription Medicines 1,289,486,567,822 15.69%

Raw Materials 670,090,472,482 8.15%

Medical devices 226,987,925,432 2.76%

Veterinary Products 22,037,426,734 0.27%

Health Care Services 2,823,368,056 0.03%

Total : 8,217,179,773,034 100%

BUSINESS OVERVIEW

Description of Net Sales per Products and The Contribution

11

Consumer Products

Rp3,664.86 billion44.60%

Prescription Medicines

Rp. 2,340.89 billion28.49%

Non Prescription

Medicines

Rp1,289.49 billion15.69%

Raw MaterialsRp670.09 billion

8.15%

Medical DevicesRp226.99 billion

2.76%

Veterinary Products

Rp22.04 billion0.27%

Health Care Services

Rp2.82 billion0.03%

Net Sales June 2014

Rp8,217.18 billion

*Growth of net sales per products as describe below :

BUSINESS OVERVIEW

All Business Line of the company were grew significantly

12

Products Portfolio Net Sales June 2014 (Rp) Net Sales June 2013 (Rp) Growth

Consumer Products 3,664,865,320,957 3,201,750,702,347 14.46%

Prescription Medicines 2,340,888,691,551 2,098,782,830,707 11.54%

Non Prescription Medicines 1,289,486,567,822 1,159,255,253,221 11.23%

Raw Materials 670,090,472,482 515,259,034,715 30.05%

Medical devices 226,987,925,432 282,284,496,196 -19.59%

Veterinary Products 22,037,426,734 20,141,529,593 9.41%

Health Care Services 2,823,368,056 1,915,484,751 47.40%

Total : 8,217,179,773,034 7,279,389,331,530 12.88%

Total NetSales

ConsumerProducts

PrescriptionMedicines

NonPrescriptionMedicines

Raw Materials MedicalDevices

VeterinaryProducts

Health CareServices

2013 2014

11.54 %

11.23 %

30.05 %-19.59 %

BUSINESS OVERVIEW

Growth of Net Sales 2013 vs 2014

13

12.88 %

9.41 % 47.40 %

14.46 %

BUSINESS OVERVIEW

The Company’s Principals

14

Non-Prescription

Prescription

Consumer Health

Tata Nutrisiana

BUSINESS OVERVIEW


15

Medical Device & Diagnostic

BUSINESS OVERVIEW


16

Raw material

Friesland Foods Domo

45 Branch 23 Branch TSJ 37 Subdist KDS/Regular 21 Sales Offices

BUSINESS OVERVIEW

National Coverage 65 Full Services Branches & More than 200,000 Direct Outlet Coverage

ENSEVAL Coverage

Type of outlet coveraged by the company’s distribution

Covers all trade channels in the market :

BUSINESS OVERVIEW

More than 200,000 direct outlet coverage

18

General / Traditional Trade Channel

• Wholesalers

• Retailers

• Provision Stores

• Convenience Stores

• Food & Beverage

• Store - Fruit Shops

• Cosmetic Stores

• etc

Modern Trade Channel

• Hypermarkets

• Supermarkets

• Mini Markets

• Departement Stores

• etc

Pharmaceutical Trade Channel

• Pharmacies

• Drugstores

• Hospitals

• Labs – Clinics

• Institutions

• etc

2014 OVERVIEW

19

Sales Contribution by Channel (June 2013 vs june 2014)

40%

32%

28%

2013

Pharmaceutical Trade

General Trade

Modern Trade

24%

39%

37%

2014

Pharmaceutical Trade

General Trade

Modern Trade

2014 OVERVIEW

20

Sales Contribution by Principal (June 2013 vs june 2014)

33.33%

66.67%

2012

External Principal Internal Principal

33.33%

66.67%

2013

External Principal Internal Principal

BUSINESS OVERVIEW

The Company’s modern trade account

21

BUSINESS OVERVIEW

200,000+ Direct Outlet Coverage

22

Pharmacy; 11.571

Hospital; 1.614

Drugstore, 4,485

Wholesaler; 2.260

Hypermarket, 178

Supermarket; 1.179

Minimarket, 3,115

Provision Store; 162.000

F&B Stores; 15.000

Cosmetics; 1.750

Others; 9.800

Covers all trade channels in the market:

- General / Traditional Trade Channel: Wholesalers, Retailers, Provision Stores, Convenience Stores, Food & Beverage Stores, Fruit Shops, Cosmetics Stores, etc

- Modern Trade Channel: Hypermarkets, Supermarkets, Mini Markets, Department Stores, etc

- Ethical Trade Channel: Pharmacies, Drugstores, Hospitals, Labs - Clinics, Institutions, etc

SECTION 3OPERATIONAL OVERVIEW

OPERATIONAL OVERVIEW

24

Mobile application (Tablet Computer & PDA)

- Supervisor: Team Performance Analysis

- Salesman & Deliveryman: Faster Order Taking & Faster Information Process

Global Information System (GIS)

- Application for more in depth sales and territory mapping .

Supported by Enseval Customer Care (ECC)

- in Branches Order Management, Complaint Handling, Basic Product Information .

Customers also can reach Enseval office via Phone, Fax & Email for easy customer ordering.


25

Centralized IT system using Oracle E-Business Solutions• Integrated & Real Time system

Use the best world-class ERP system by Oracle Complete Oracle E-Business SuiteOracle Warehouse Management System (WMS)Advance Supply Chain Planning (ASCP) and Oracle Demantra

Tablet Computer & PDA system E-Mobile ®2,300+ PDA used by Supervisors, Salesmen, Deliverymen, & Collectors Menu: Distribution Plan, Distribution Achievement, Overdue, etc

Provide data security for antivirus by Trend Micro and Sonic Wall

IT Infrastructure


26

• ENI (Enseval Net Info) • Web based application

• Sales (hourly updated) & Stock (D-1)

• EXI (Enseval Xpress Info)• SMS based application

• Sales & Stock Report

• ERI (Enseval Raw Data Info)• Raw Data format, distribution and logistics information activities

• ENO (Enseval NET Order)

• Online order with business-to-business system

For Principal

For Customer

Comprehensive Business Access

SECTION 4FINANCIAL OVERVIEW

FINANCIAL OVERVIEW

Net Sales Growth

28

7,279.39 6,497.378,217.18 7,311.16

2013 2014

89.26%88.97%

- 0.28%

12.88%12.52%

: Net Sales 30 June 2013 in Rp/billion : COGS 30 June 2013 in Rp/billion

: Net Sales 30 June 2014 in Rp/billion : COGS 30 June 2014 in Rp/billion

: COGS Margin

Net Sales COGS

30 June 2013 (Unaudited)




782.02

906.02

FINANCIAL OVERVIEW

Expense Ratio

29

15.86%



Gross Profit

Gross Profit Margin

Gross Profit (Rp/Billion)

10.74%11.03%0.28%

437.98

498.31

13.77%



Operational Expense

Operational Expense Margin

Operational Expense (Rp/Billion)

6.85%

5.34%

-1.50%

FINANCIAL OVERVIEW

Profit Growth (Juni 2013 vs Juni 2014)

30

283.71 292.11218.05

281.79 298.94219.20

0.68% 2.34%

0.53%

Operating Profit Margin Income Before Tax Expense Margin

Income For The Year Margin







3.90%3.43%

-0.47%

Operating Profit(Rp/Billion)

Income Before Tax Expense (Rp/Billion)

Operating Profit Income Before Tax Expense Income For The Year

4.01%3.64%

-0.37% 3.00%2.67%

-0.33%

FINANCIAL OVERVIEW

Financial Position (December 2013 vs June 2014)

31

5,528.07

2,489.22 3,038.85

5,909.19

2,649.62 3,259.56

6.89%

6.44%7.26%

31 Dec 2013 (Audited)


Total Assets (Rp/Billion) Total Liabilities (Rp/Billion)




30 June 2014(Unaudited)

SECTION 52014 OVERVIEW

Warehouse Management System-Oracle-based WMS

-Manage stock from

inbound-outbound,

by location, SKU, Batch Number,

Expiry Date

-Bar-coding system with mobile bar-code reader to eliminate duplication & increase accurate operation

Cold Chain Management-Enseval has implemented and Standardized Cold Chain Management in it’s RDC, Branch Warehouse, and Transportation according to ISO 9001:2008.

-Cold Chain Management is performed with close control

-All activities is always recorded and stored properly

Cold Chain Handling in Enseval Delivery with Temperature Controlled Transportation

Temperature MonitoringDocument

Standardized FacilitiesStandardized Branches (Full Services)

Strategic Value to Business Partners• Strong product portfolio.

• Sustainable business growth.

• Supported by 2 RDC, 45 branches, 13 Sales Office, & 200,000+ direct coverage outlets.

Market Leading Position in Indonesia

• 40+ years of strategic expertise in distribution and logistics service.

• Strong and good relationship with all business players : Principals & Outlets.

• Having in aggregate over 100 years of experience senior management team and supported by more than 5000 employees.

Reliable Partner to Grow

• Public listed company with professional management that treats all business partners equally with the utmost transparency and accountability.

• Independent business entity with neutrality to ensure fairness to all stakeholders.Transparency and Neutrality

• Robust balance sheet figures.

• Solid financial performance.Strong Financial Track Record

• Commitment to assist & support Principal to achieve it’s goals.

• Implementation of Continuous Improvement (CONIM) in all business aspects by Enseval’s employees in every level.

Enseval’s Commitment Towards Improvement

FORWARD LOOKING STATEMENTThis presentation has been prepared for informational purposes only by PT Enseval Putera Megatrading Tbk. ("Enseval" or the "Company")

This presentation has been prepared solely for use in connection with the release 0f 30 june 2013 unaudited results of the Company. The information containedin this presentation has not been independently verified. No representation, warranty or undertaking, express or implied, is made as to, and no reliance shouldbe placed on, the fairness, accuracy, completeness or correctness of the information or the opinions contained herein. None of the Company or any of theirrespective affiliates, and their respective commissioners, directors and employees, advisors or representative shall have any liability whatsoever (in negligenceor otherwise) for any loss however arising from any use of this presentation or its contents or otherwise arising in connection with the presentation. Anydecision to purchase or subscribe for securities of the Company should not be made on the basis of the information contained in this presentation.The presentation is not an offer of securities for sale in the United States. Securities may not be offered or sold in the United States absent registration or anexemption from registration.This presentation and its contents are confidential unless they are become generally avaiable as public information in accordance with prevailing lawsregulations (other than as a result of a disclosure by you) and must not be distributed, published or reproduced (in whole or in part) or disclosed by receipentsto any other person. This presentation does not constitute a recommendation regarding the securities of the Company.This presentation, including the information and opinions contained herein, is provided as the date of this presentation and is subject to change without notice,including change as a result of the issuance of 30 June 2013 unaudited results of the Company.This presentation includes "forward-looking statements". These statements contain the words "anticipate", "believe", "intend", "estimate", "expect" and wordsof similiar meaning. All statements other than statements of historical facts included in this presentation, including, without limitation, those regarding theCompany's financial position, business strategy, plans and objectives of management for future operations (including development plans, objectives relating tothe Company's products and services and anticipated product launches) are forward-looking statements. Such forward-looking statements are based onnumerous assumptions regarding the Company's present and future business strategies and the environment in which of the Company will operate in thefuture. These forward-looking statements speak only ast the date of this presentation. The Company expressly disclaims any obligation or reflection of anychange in the Company's expectations with regard thereto, or any change in events, conditions or circumtances on which any statements is based.Market data and certain industry forecast used in this presentation were obtained from market research, publicity avaiable information and industrypublications which have not been independently verified, and no presentation is made as to the accuracy of such information.

THANK YOUFor Further Information:

Corporate SecretaryPT Enseval Putera Megatrading Tbk.Enseval BuildingKawasan Industri PulogadungJalan Pulolentut No. 10Jakarta 13920 – IndonesiaPhone : 62-21-46822422 Fax : 62-21-4609039Website : www.enseval.comEmail : [email protected]

PT ENSEVAL PUTERA MEGATRADING TBK. · name to PT Enseval Putera Megatrading 1994 –PT Enseval...

Documents

Transcript of PT ENSEVAL PUTERA MEGATRADING TBK. · name to PT Enseval Putera Megatrading 1994 –PT Enseval...